AbbVie Inc AbbVie (NYSE: ABBV) to Ends its Collaboration with BioArctic AbbVie Inc. (NYSE: ABBV) has decided to end its partnership with BioArctic regarding the portfolio of alpha-synuclein antibodies, including ABBV-0805. BioArctic and AbbVie have joined hands since 2016 regarding the
